Description
Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea.
Indications
Gliclazide is indicated in patients with type 2 diabetes when diet and exercise do not result in adequate glycemic control.
Subject to medical prescription
Pharmaceutical form: 80 mg x 60 film-coated tablets
NHIF code: AF317 ICD: E11.2, E11.3, E11.4, E11.5, E11.9
Description
Hydrochlorothiazide is a first line diuretic drug of the thiazide class that acts by inhibiting the kidneys’ ability to retain water.
Indications
- Hypertension (as monotherapy or in combination with other antihypertensive drugs).
- Edema and congestive heart failure.
- Nephrogenic diabetes insipidus.
- Idiopathic hypercalciuria and prophylaxis of recidives of calcium calculi formation.
Subject to medical prescription
Pharmaceutical form: 25 mg x 30 tablets
NHIF code: CF 605
ICD: I10; I11.0, I11.9, I12.0, I12.9, I13.0, I13.1, I13.2 ; I50.0; I50.1
Description
Verapamil is an L-type calcium channel blocker of the Phenylalkylamine class.
Indications
– Essential hypertension (mild to moderate)
All pharmaceutical forms of Verapamil Tchaikapharma are indicated for treatment of low or medium-degree essential hypertension
– IHD – stable angina or Prinzmetal’s angina in patients with normal leftventricular function
– Arrhythmias – prevention of supraventricular tachycardia, ventricular rate control in patients with atrial fibrillation
Although Verapamil -Tchaikapharma prolonged-release tablets are effective for treatment of angina pectoris as well as arrhythmias, according to the newer clinical experience, better results are achieved in these indications with other pharmaceutical forms of Verapamil (conventional tablets and injections).
Subject to medical prescription
Pharmaceutical form: 40 mg x 30 coated tablets
NHIF code: CF 168
ICD: I10, I11.9, I12.9, I13.1, I20.1, I20.8, I20.9, I45.6, I47.1, I48
Pharmaceutical form: 80 mg x 50 coated tablets
NHIF code: CF 545
ICD: I10, I11.9, I12.9, I13.1, I20.1, I20.8, I20.9, I45.6, I47.1, I48
Pharmaceutical form: 240 mg x 20 prolonged-release tablets
NHIF code: CF 546
ICD: I10, I11.9, I12.9, I13.1, I20.1, I20.8, I20.9, I45.6, I47.1, I48
Description
Nebivolol is a β1-receptor blocker with nitric oxide-potentiating vasodilatory effect used in treatment of hypertension and, also for left ventricular failure.
Indications
• Treatment of essential hypertension
• Treatment of stable mild and moderate chronic heart failure (CHF) in patients aged 70 or over, in addition to other therapies.
Subject to medical prescription
Pharmaceutical form: 5 mg x 30 tablets
NHIF code: CF 815
ICD: I10, I11.0, I11.9, I12.0, I12.9, I13.0, I13.1, I13.2;
I50.0, I50.1 – in patients older than 70 years
